| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217683 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 8 Pages |
Abstract
Plasma profiling of specific metabolites related to pyrimidine and tryptophan pathways can be used to differentiate whole-body radiation injury and dose response. As the tryptophan-associated indole compounds have their origin in the intestinal microbiome and subsequently the liver, these metabolites particularly represent an attractive marker for radiation injury within blood plasma.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Pilib PhD, Bhavapriya PhD, Subhrajit PhD, Kirsten PhD, Emily I. PhD, Devorah PhD, William Harv MD, PhD, Irwin J. MD, PhD, Chandan MBBS, PhD, Aaron PhD,